USPTO serial 79267511
SIBNAYAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 11, 2020
- Examiner
- SNAPP, TINA LOUISE
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with SIBNAYAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $425
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mary Margaret L. O'Donnell
Mary Margaret L. O'Donnell Blue Filament Law PLLC772 E. Maple RoadBirmingham, MI 48009United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Dietary supplements and dietetic foods and beverages adapted for medical use; diagnostic preparations for medical purposes; surgical implants comprised of living organs and tissues; medical dressings and plasters for application on the skin; ] pharmaceuticals and natural remedy preparations for the treatment of nephrological, hematological or neurological diseases; [ medical adhesives for affixing prostheses; alcohol for pharmaceutical purposes; amino acid preparations for medical purposes; insecticides, namely, flea dip preparations; amino acid preparations for veterinary use; animal semen for artificial insemination; animal sperm; antibiotics for fish; antibiotic food supplements for animals; antipyretic preparations; arsenic detoxification agents for medical purposes; attractants for pet animals, namely, pet training aids in the form of drops to toilet train animals; bacterial poisons; bacterial preparations for medical and veterinary use; bacterial preparations for veterinary purposes; bacterial preparations for medical purposes; bacteriological preparations for medical purposes; bacteriological preparations for veterinary purposes; bark extract for veterinary use; bark powder for medical use; bark extract for medical use; cachets for medicinal purposes, namely, drug delivery agents in the form of microgranules; by-products of the processing of cereals for medical purposes; medicated chewing gum for nephrological, hematological or neurological diseases; medicated oral irrigating solution used in treating breath malodor; bone growth media consisting of biological materials for medical purposes; bone cements for surgical purposes; bone cements for orthopaedic purposes; bone cement for surgical and orthopaedic purposes; bone cement for medical purposes; blood substitutes for human use; blood protein fractions for medical diagnostics and medical therapeutic purposes; blood plasma; blood for medical purposes; blood components in the nature of platelet rich blood plasma and stem cells for medical use; biological tissue cultures for veterinary purposes; biological tissue cultures for medical purposes; veterinary biological preparations for the treatment of nephrological, hematological or neurological diseases; medical biological preparations for the treatment of nephrological, hematological or neurological diseases; biological indicators for monitoring sterilization processes for medical or veterinary purposes; veterinary biochemical preparations for the treatment of nephrological, hematological or neurological diseases; ] medical biochemical preparations for the treatment of nephrological, hematological or neurological diseases; [ benzol detoxification agents for medical purposes; bath salts for medical purposes; bath preparations for medical purposes; nutritional supplements, namely, bark powder for veterinary use; cord blood for medical purposes; cooling sprays for medical purposes; contraceptive sponges; contraceptive foams; collodion for pharmaceutical purposes; collagen for medical purposes; chromatographic supports for medical use, namely, drug delivery agents in the form of coatings for tablets that facilitate the delivery of wide range of pharmaceuticals; chlorine detoxification agents for medical purposes; chemical reagents for veterinary purposes; chemical reagents for medical purposes; chemical contraceptives; chemical contraceptive sponges; cement for animal hooves; cellulose ethers for pharmaceutical purposes; cellulose esters for pharmaceutical purposes; cellular function activating agents for medical purposes; caustic pencils; castor oil as a coating for pharmaceuticals; cardiovascular agents for medical purposes; capsules sold empty for pharmaceuticals; specialized capsules for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; cantharides preparations for veterinary use; cachets for pharmaceutical purposes; cantharides preparations for medical use; gases and gas mixtures for medical imaging use; gas mixtures for medical imaging use; dietary supplements, namely, fodder additives for animals; first-aid boxes, filled; first aid kits for domestic use; feeding stimulants for animals; feed supplements for veterinary use; eye drops; enzymes for veterinary purposes; enzymes for medical purposes; enzyme preparations for veterinary purposes; enzyme preparations for medical purposes; enema preparations; ear candles for therapeutic purposes; drug delivery agents consisting of compounds that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; douching preparations for medical purposes; Medicated dog skin lotions for veterinary purposes; diagnostic radiopharmaceutical preparations; dextrins for pharmaceutical use; Medicated bath crystals for therapeutic purposes; corn remedies, namely, corn pads and plasters; ] medical preparations for the treatment of nephrological, hematological or neurological diseases; [ medical adhesives for binding wounds; medical adhesives for binding internal tissue; materials for surgical casts, namely, surgical plasters; lubricants for surgical purposes; lubricants for medical use; medicated hair lotions for veterinary purposes; living cells for veterinary use; leeches for medical purposes; isotopes for medical purposes; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; injectable dermal filler; medicated wipes impregnated with antibacterial preparations; hydrogen peroxide for medical purposes; herbal sore skin ointments for pets; herbal anti-itch ointments for pets; haemostatic pencils; haemoglobin; greases for veterinary purposes; greases for medical purposes; greases for medical or veterinary purposes; gravel as a digestive aid for birds; gelatine for medical purposes; gases for medical purposes; nucleic acid sequences for medical and veterinary purposes; medicinal mud for baths; mixed biological preparations for medical purposes, namely, for the treatment of nephrological, hematological or neurological diseases; mineral waters for medical purposes; medicated mineral water bath salts; mineral preparations for medical purposes; dietetic mineral food preparations adapted for medical purposes; milking grease for medical purposes; milk sugar for medical purposes; microbicides for human use; veterinary medicines for the treatment of nephrological, hematological or neurological diseases; medicinal mud; ] medicinal healthcare preparations for the treatment of nephrological, hematological or neurological diseases [ ; medicinal clay preparations; medicinal alcohol; medicated toiletry preparations; medicated shampoos for pets; medicated shampoos; medicated eye-washes; medicated dry shampoos; medicated baby oils; medicated after-shave lotions; medicated additives for animal foods to assist in digestion; radiotherapeutic hormones; radioactive substances for medical purposes; radioactive elements for medical use; radio-isotope markers for therapeutic or diagnostic use; radiation sickness treating agents; preparations of trace elements for human and animal use, namely, dietary and nutritional supplements; medical preparations for use in naturopathy, namely, natural sleep aid preparations; portable first-aid kits; pheromones for medical use; veterinary pharmaceutical preparations for the treatment of nephrological, hematological or neurological diseases; pharmaceutical preparations for animals for the treatment of nephrological, hematological or neurological diseases; petroleum jelly for medical or veterinary purposes; pearl powder for medical purposes; paracetamol preparations for oral administration; paracetamol preparations for intravenous administration; paracetamol modified release preparations; panthenol preparations for medical use, namely, for the treatment of nephrological, hematological or neurological diseases; pain relief medication for veterinary purposes; oxygen baths for medical use; organotherapeutics; oral vaccine preparations; oral rehydration salts; oiled paper for medical purposes; nutritional supplements for veterinary use; therapeutic medicated preparations for the bath; disinfectants, namely, teat dips for dairy cows; surgical glues; surgical cements; stem cells for veterinary purposes; stem cells for medical purposes; solvents for removing adhesive plasters for medical purposes; solidified gases for medical purposes; solid oxygen for medical use; semen for artificial insemination; sealed radioactive substances for medical use; sea water for medicinal bathing; medicated skin scrubs for medical use; sanitary preparations for veterinary use; sandalwood oil for medical, pharmaceutical and veterinary purposes; medicated salts for mineral water baths; rubbing alcohol; repellents for dogs; rehydration preparations, namely, oral rehydration salts; reconstituted cells for medical skin care treatments; reconstituted cells for clinical skin care treatments; reagents for use in veterinary genetic testing; reagents for use in medical genetic testing; reagents for medical use; radium for medical purposes; yeast for medical, veterinary or pharmaceutical purposes; yeast extracts for medical, veterinary or pharmaceutical purposes; vascular grafts of living tissue; human vaccine preparations; vaccines; urease for medical purposes; medicated udder creams for agricultural use; tryptophane preparations; trypsins for medical purposes; trichomycin preparations; trace element preparations for use by animals, namely, dietary and nutritional supplements; trace element preparations for human use, namely, dietary and nutritional supplements; tobacco-free cigarettes for smoking cessation purposes; thermal water, namely, mineral enhanced water for medical purposes ] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 30, 2026 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Sep 21, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 7, 2026 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Aug 11, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 28, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 26, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 4, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 3, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 11, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 11, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 5, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 26, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 26, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 20, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 20, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 6, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 17, 2020 | ALIE | ASSIGNED TO LIE | — |
| Apr 8, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 8, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 8, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 8, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 8, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 27, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 27, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 27, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 27, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 27, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 27, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Feb 27, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 27, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 27, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 16, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 31, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 31, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 10, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 9, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 23, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 23, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 19, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |